This inventor holds 4 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Genemedicine Co., Ltd., Industry-University Cooperation Foundation Hanyang University, Yonsei University. Active years: 2011-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12 
1 out of 1,245 
1 out of 1,492 
Years Active: 2011-2017
Title: Joo-Hang Kim: Pioneering Innovations in Gene Therapy
Introduction
Joo-Hang Kim, based in Seoul, South Korea, is a prominent inventor known for his contributions to the field of genetic engineering and cancer treatment. With a total of four patents, his work focuses on leveraging recombinant adenoviruses for therapeutic applications, specifically in regulating angiogenesis and enhancing gene delivery systems.
Latest Patents
Kim's latest patents demonstrate a remarkable approach to genetic therapy. One notable invention is a recombinant adenovirus capable of regulating angiogenesis. This invention includes an adenoviral UR nucleotide sequence along with a transcription regulatory sequence for the VEGF-A gene, designed to interact with specific sites in the VEGF-A promoter. Additionally, he has developed a novel decorin gene delivery system that incorporates a decorin-encoding sequence to improve transgene transduction efficiency, along with pharmaceutical compositions for anti-tumor applications.
Career Highlights
Throughout his career, Joo-Hang Kim has made significant strides in biotechnology, particularly within gene therapy and cancer treatment realms. His innovations have set a new standard for approaches to tackling diseases linked to the accumulation of excess extracellular matrix, showcasing his commitment to advancing medical science.
Collaborations
In his professional journey, Kim has collaborated with noteworthy individuals in the field, including Chae-Ok Yun and Jin Soo Kim. These partnerships illustrate the collaborative spirit prevalent in research environments and underline the importance of teamwork in achieving groundbreaking innovations.
Conclusion
Joo-Hang Kim’s work exemplifies the transformative potential of inventions in the medical field. His advancements in recombinant adenoviruses not only highlight his creativity and expertise but also contribute meaningfully to contemporary therapies in cancer treatment and gene delivery systems. As he continues to innovate, the impact of his discoveries is sure to resonate in the realms of biotechnology and medicine for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile